Heron Therapeutics Inc (HRTX)
3.20
-0.02
(-0.62%)
USD |
NASDAQ |
May 17, 16:00
3.20
0.00 (0.00%)
After-Hours: 20:00
Heron Therapeutics Cash from Investing (Quarterly): 1.278M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.278M |
| December 31, 2023 | -8.836M |
| September 30, 2023 | -23.22M |
| June 30, 2023 | 13.22M |
| March 31, 2023 | 36.83M |
| December 31, 2022 | 2.021M |
| September 30, 2022 | -36.05M |
| June 30, 2022 | 19.76M |
| March 31, 2022 | 10.95M |
| December 31, 2021 | -24.26M |
| September 30, 2021 | 21.63M |
| June 30, 2021 | 39.70M |
| March 31, 2021 | -4.344M |
| December 31, 2020 | 56.79M |
| September 30, 2020 | 55.94M |
| June 30, 2020 | 32.41M |
| March 31, 2020 | 63.82M |
| December 31, 2019 | -126.36M |
| September 30, 2019 | 28.63M |
| June 30, 2019 | 41.84M |
| March 31, 2019 | 34.11M |
| December 31, 2018 | 8.328M |
| September 30, 2018 | -149.26M |
| June 30, 2018 | -97.33M |
| March 31, 2018 | -40.29M |
| Date | Value |
|---|---|
| December 31, 2017 | -20.36M |
| September 30, 2017 | 70.61M |
| June 30, 2017 | 2.41M |
| March 31, 2017 | -44.92M |
| December 31, 2016 | 4.811M |
| September 30, 2016 | -31.15M |
| June 30, 2016 | 18.56M |
| March 31, 2016 | 22.66M |
| December 31, 2015 | -56.42M |
| September 30, 2015 | -0.252M |
| June 30, 2015 | 0.038M |
| March 31, 2015 | -0.328M |
| December 31, 2014 | -1.021M |
| September 30, 2014 | -0.082M |
| June 30, 2014 | -0.278M |
| March 31, 2014 | -0.057M |
| December 31, 2013 | -0.167M |
| September 30, 2013 | -0.977M |
| June 30, 2013 | -0.106M |
| March 31, 2013 | -0.435M |
| December 31, 2012 | -0.426M |
| September 30, 2012 | -0.079M |
| June 30, 2012 | -0.044M |
| March 31, 2012 | -0.423M |
| December 31, 2011 | -0.387M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-126.36M
Minimum
Dec 2019
63.82M
Maximum
Mar 2020
10.09M
Average
16.49M
Median
Cash from Investing (Quarterly) Benchmarks
| United Therapeutics Corp | 735.30M |
| Esperion Therapeutics Inc | -0.073M |
| Aldeyra Therapeutics Inc | -30.38M |
| Ocular Therapeutix Inc | -0.255M |
| Alpine Immune Sciences Inc | -2.562M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.516M |
| Cash from Financing (Quarterly) | 0.011M |
| Free Cash Flow | -43.40M |
| Free Cash Flow Per Share (Quarterly) | -0.0629 |
| Free Cash Flow to Equity (Quarterly) | -9.752M |
| Free Cash Flow Yield | -9.57% |